Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Feb-24 7:13 PM View:  | Dyne Therapeutics, Inc. (DYN) | 28-Feb-24 | Sale (Planned) | 154,674 | $24.84 | $3,841,580.00 | (2%) 8.24M to 8.09M | |
| 28-Feb-24 7:13 PM View: | Dyne Therapeutics, Inc. (DYN) | 28-Feb-24 | Sale (Planned) | 36,246 | $24.84 | $900,228.00 | (< 1%) 8.09M to 8.05M | |
| 28-Feb-24 7:13 PM View: | Dyne Therapeutics, Inc. (DYN) | 27-Feb-24 | Sale (Planned) | 298,702 | $24.41 | $7,290,090.00 | (3%) 8.61M to 8.31M | |
| 28-Feb-24 7:13 PM View: | Dyne Therapeutics, Inc. (DYN) | 27-Feb-24 | Sale (Planned) | 69,997 | $24.41 | $1,708,340.00 | (< 1%) 8.31M to 8.24M | |
| 28-Feb-24 7:13 PM View: | Dyne Therapeutics, Inc. (DYN) | 26-Feb-24 | Private Sale (Planned) | 201,095 | $23.72 | $4,769,100.00 | (2%) 8.86M to 8.66M | |
| 28-Feb-24 7:13 PM View: | Dyne Therapeutics, Inc. (DYN) | 26-Feb-24 | Sale (Planned) | 47,124 | $23.72 | $1,117,580.00 | (< 1%) 8.66M to 8.61M | |
| 23-Feb-24 6:58 PM View: | Dyne Therapeutics, Inc. (DYN) | 23-Feb-24 | Sale (Planned) | 159,542 | $22.70 | $3,621,600.00 | (2%) 9.06M to 8.9M | |
| 23-Feb-24 6:58 PM View: | Dyne Therapeutics, Inc. (DYN) | 23-Feb-24 | Sale (Planned) | 37,386 | $22.70 | $848,662.00 | (< 1%) 8.9M to 8.86M | |
| 23-Feb-24 6:58 PM View: | Dyne Therapeutics, Inc. (DYN) | 22-Feb-24 | Sale (Planned) | 119,360 | $22.66 | $2,704,700.00 | (1%) 9.17M to 9.06M | |
| 23-Feb-24 6:58 PM View: | Dyne Therapeutics, Inc. (DYN) | 21-Feb-24 | Private Sale (Planned) | 184,501 | $22.57 | $4,164,820.00 | (2%) 9.36M to 9.17M | |
| 20-Feb-24 6:35 PM View: | Dyne Therapeutics, Inc. (DYN) | 20-Feb-24 | Sale (Planned) | 169,539 | $22.72 | $3,852,650.00 | (2%) 6.99M to 6.82M | |
| 20-Feb-24 6:35 PM View: | Dyne Therapeutics, Inc. (DYN) | 16-Feb-24 | Sale (Planned) | 162,707 | $23.14 | $3,765,040.00 | (2%) 7.15M to 6.99M | |
| 20-Feb-24 6:35 PM View: | Dyne Therapeutics, Inc. (DYN) | 15-Feb-24 | Private Sale (Planned) | 177,906 | $23.89 | $4,249,600.00 | (2%) 7.33M to 7.15M | |
| 09-Feb-24 4:33 PM View: | Xilio Therapeutics, Inc. (XLO) | 08-Feb-24 | Sale | 733 | $0.64 | $469.12 | (< 1%) 2.76M to 2.75M | |
| 09-Feb-24 4:33 PM View: | Xilio Therapeutics, Inc. (XLO) | 08-Feb-24 | Sale | 267 | $0.64 | $170.88 | (< 1%) 2.75M to 2.75M | |
| 16-Jan-24 6:16 PM View: | Xilio Therapeutics, Inc. (XLO) | 12-Jan-24 | Sale | 1,540 | $0.83 | $1,278.20 | (< 1%) 2.76M to 2.76M | |
| 16-Jan-24 6:16 PM View: | Xilio Therapeutics, Inc. (XLO) | 12-Jan-24 | Sale | 560 | $0.83 | $464.80 | (< 1%) 2.76M to 2.76M | |
| 16-Jan-24 6:16 PM View: | Xilio Therapeutics, Inc. (XLO) | 11-Jan-24 | Sale | 1,566 | $0.87 | $1,362.42 | (< 1%) 2.76M to 2.76M | |
| 16-Jan-24 6:16 PM View: | Xilio Therapeutics, Inc. (XLO) | 11-Jan-24 | Sale | 569 | $0.87 | $495.03 | (< 1%) 2.76M to 2.76M | |
| 14-Dec-22 4:54 PM View: | Day One Biopharmaceuticals,... (DAWN) | 12-Dec-22 | Disposition (other) | 600,854 | -- | -- | (9%) 6.61M to 6.01M | |
| 21-Sep-22 4:58 PM View: | Day One Biopharmaceuticals,... (DAWN) | 19-Sep-22 | Disposition (other) | 600,854 | -- | -- | (8%) 7.21M to 6.61M | |
| 19-Sep-22 4:51 PM View: | Third Harmonic Bio, Inc. (THRD) | 19-Sep-22 | Conversion | 7,066,470 | -- | -- | 200% 3.54M to 10.61M | |
| 19-Sep-22 4:51 PM View: | Third Harmonic Bio, Inc. (THRD) | 19-Sep-22 | Market Purchase | 300,000 | $17.00 | $5,100,000.00 | 3% 10.61M to 10.91M | |
| 14-Dec-21 8:27 PM View: | Ikena Oncology, Inc. (IKNA) | 14-Dec-21 | Market Sale | 5,959 | $14.00 | $83,426.00 | (< 1%) 2.12M to 2.12M | |
| 14-Dec-21 8:27 PM View: | Ikena Oncology, Inc. (IKNA) | 13-Dec-21 | Market Sale | 8,330 | $14.64 | $121,951.00 | (< 1%) 2.13M to 2.12M | |
| 14-Dec-21 8:27 PM View: | Ikena Oncology, Inc. (IKNA) | 10-Dec-21 | Market Sale | 11,989 | $15.03 | $180,195.00 | (< 1%) 2.14M to 2.13M | |
| 29-Nov-21 5:30 PM View: | Day One Biopharmaceuticals,... (DAWN) | 24-Nov-21 | Disposition (other) | 801,138 | -- | -- | (10%) 8.01M to 7.21M | |
| 26-Oct-21 5:01 PM View: | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 2,545,530 | -- | -- | 9673% 26.31K to 2.57M | |
| 26-Oct-21 5:01 PM View: | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Market Purchase | 187,500 | $16.00 | $3,000,000.00 | 7% 2.57M to 2.76M | |
| 15-Jul-21 4:33 PM View: | Dyne Therapeutics, Inc. (DYN) | 13-Jul-21 | Disposition (other) | 814,013 | -- | -- | (10%) 8.14M to 7.33M | |
| 02-Jun-21 6:40 PM View: | Day One Biopharmaceuticals,... (DAWN) | 01-Jun-21 | Conversion Duplicate | 8,502,780 | -- | -- | (100%) (-8.5M) to 0 | |
| 02-Jun-21 6:40 PM View: | Day One Biopharmaceuticals,... (DAWN) | 01-Jun-21 | Purchase | 500,000 | $16.00 | $8,000,000.00 | 100% 0 to 500.0K | |
| 14-Dec-21 8:27 PM View: | Ikena Oncology, Inc. (IKNA) | 30-Mar-21 | Purchase | 125,000 | $16.00 | $2,000,000.00 | 6% 2.02M to 2.14M | |
| 23-Sep-20 6:56 PM View: | Dyne Therapeutics, Inc. (DYN) | 21-Sep-20 | Conversion | 7,638,510 | -- | -- | 362% 2.11M to 9.75M | |
| 02-Jan-20 5:19 PM View: | Akero Therapeutics, Inc. (AKRO) | 31-Dec-19 | Disposition (other) | 242,883 | -- | -- | (8%) 2.95M to 2.71M | |
| 19-Dec-19 5:34 PM View: | Akero Therapeutics, Inc. (AKRO) | 17-Dec-19 | Disposition (other) | 570,974 | -- | -- | (14%) 3.97M to 3.4M | |
| 25-Jun-19 6:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 24-Jun-19 | Conversion Duplicate | 3,704,860 | -- | -- | 100% 0 to 3.7M | |
| 25-Jun-19 6:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 24-Jun-19 | Purchase | 270,000 | $16.00 | $4,320,000.00 | 7% 3.7M to 3.97M |